NPI: 1720078702 · WELLINGTON, FL 33414 · General Acute Care Hospital · NPI assigned 10/21/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 10/21/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 30,131 | $541K |
| 2019 | 79,028 | $1.46M |
| 2020 | 64,454 | $1.23M |
| 2021 | 77,032 | $1.96M |
| 2022 | 87,703 | $2.83M |
| 2023 | 50,548 | $1.89M |
| 2024 | 20,331 | $835K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,487 | 22,715 | $2.39M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 30,960 | 25,959 | $1.91M |
| G0378 | Hospital observation service, per hour | 5,190 | 2,108 | $1.32M |
| 36415 | Collection of venous blood by venipuncture | 33,862 | 23,523 | $1.06M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,901 | 4,183 | $718K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,688 | 5,964 | $654K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,311 | 3,590 | $579K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,812 | 2,526 | $247K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,862 | 1,283 | $192K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6,556 | 5,869 | $163K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,820 | 1,238 | $103K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 562 | 500 | $94K |
| 59025 | Fetal non-stress test | 3,210 | 2,462 | $87K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,895 | 5,886 | $85K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,696 | 1,439 | $79K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,059 | 1,714 | $71K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,241 | 1,082 | $70K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 327 | 286 | $54K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,269 | 2,141 | $54K |
| 81001 | 11,878 | 10,130 | $50K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,141 | 6,846 | $48K |
| 71045 | Radiologic examination, chest; single view | 9,512 | 8,020 | $37K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,067 | 914 | $36K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,375 | 2,029 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,765 | 3,143 | $33K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,811 | 9,762 | $33K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 370 | 339 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,046 | 1,747 | $28K |
| 80053 | Comprehensive metabolic panel | 17,845 | 14,576 | $25K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 898 | 789 | $25K |
| 73130 | 479 | 430 | $23K | |
| 81003 | 3,536 | 3,092 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 11,547 | 7,360 | $18K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,127 | 1,021 | $18K |
| 76801 | 2,188 | 1,732 | $17K | |
| 87070 | 728 | 598 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 931 | 831 | $16K |
| 82962 | 3,432 | 1,688 | $15K | |
| 81025 | 5,761 | 5,116 | $14K | |
| 73630 | 530 | 472 | $14K | |
| 76818 | 205 | 161 | $13K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 132 | 123 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,908 | 4,491 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,940 | 6,292 | $11K |
| 84112 | 93 | 85 | $11K | |
| 73610 | 428 | 380 | $10K | |
| 73564 | 529 | 448 | $10K | |
| A9270 | Non-covered item or service | 6,816 | 1,635 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,083 | 20,440 | $9K |
| 87077 | 1,051 | 568 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 450 | 388 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,658 | 6,730 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 458 | 413 | $6K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 354 | 319 | $5K |
| 70486 | 58 | 54 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,348 | 6,852 | $5K |
| 85027 | 3,367 | 2,496 | $5K | |
| 99499 | 102 | 95 | $5K | |
| 85610 | 5,478 | 4,463 | $5K | |
| 87634 | 813 | 746 | $5K | |
| 12011 | 55 | 50 | $5K | |
| J2704 | Injection, propofol, 10 mg | 2,201 | 1,887 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 192 | 165 | $5K |
| 73030 | 289 | 239 | $5K | |
| 85730 | 5,167 | 4,201 | $4K | |
| 86900 | 3,934 | 3,296 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,198 | 978 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,897 | 1,604 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,814 | 1,568 | $4K |
| 86850 | 3,180 | 2,652 | $4K | |
| 87186 | 693 | 469 | $4K | |
| 84484 | 6,850 | 4,188 | $4K | |
| 73110 | 156 | 139 | $3K | |
| 86901 | 3,934 | 3,295 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,988 | 1,749 | $3K |
| 93971 | 291 | 261 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 271 | 237 | $2K |
| 72131 | 15 | 13 | $2K | |
| 72100 | 209 | 182 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 622 | 568 | $2K |
| 87040 | 1,907 | 1,027 | $2K | |
| 83690 | 6,982 | 5,946 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 168 | 149 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,106 | 866 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,670 | 1,351 | $1K |
| 74018 | 36 | 32 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,164 | 924 | $1K |
| 76830 | Ultrasound, transvaginal | 220 | 202 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 596 | 540 | $1K |
| 83735 | 2,922 | 2,173 | $1K | |
| 83880 | 1,282 | 1,044 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,237 | 1,039 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,022 | 3,104 | $1K |
| 84439 | 1,203 | 1,023 | $937.11 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 387 | 339 | $812.35 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,864 | 1,638 | $726.77 |
| 82570 | 124 | 96 | $537.91 | |
| 87430 | 308 | 279 | $524.77 | |
| 84703 | 3,874 | 3,453 | $520.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,578 | 4,812 | $506.82 |
| 76819 | Fetal biophysical profile; without non-stress testing | 222 | 185 | $506.62 |
| 84702 | 3,146 | 2,375 | $478.28 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 16 | 13 | $472.26 |
| 85379 | 839 | 737 | $422.63 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 270 | 205 | $401.97 |
| 83605 | 787 | 608 | $389.74 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 71 | 65 | $225.05 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 622 | 568 | $219.80 |
| J2060 | Injection, lorazepam, 2 mg | 307 | 250 | $190.41 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 439 | 209 | $144.84 |
| 80076 | 222 | 181 | $119.06 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 674 | 579 | $107.06 |
| 72040 | 18 | 14 | $98.67 | |
| 90715 | 81 | 68 | $75.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 818 | 678 | $69.05 |
| 85018 | 176 | 154 | $62.30 | |
| 80061 | Lipid panel | 212 | 176 | $59.60 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 762 | 645 | $58.39 |
| 96376 | 491 | 366 | $29.52 | |
| 82550 | 299 | 243 | $5.89 | |
| 87340 | 12 | 12 | $5.22 | |
| 84156 | 126 | 95 | $3.12 | |
| 85651 | 14 | 13 | $2.19 | |
| 0353U | 175 | 157 | $0.00 | |
| 73080 | 20 | 15 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 210 | 193 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 698 | 620 | $0.00 |
| 97803 | 141 | 129 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 169 | 79 | $0.00 |
| 84550 | 12 | 12 | $0.00 | |
| 87210 | 15 | 14 | $0.00 | |
| 87075 | 24 | 12 | $0.00 | |
| 86140 | 360 | 306 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 44 | 39 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 79 | 67 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 42 | 27 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 19 | 12 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 16 | 12 | $0.00 |
| 97802 | 14 | 14 | $0.00 | |
| 97162 | 13 | 12 | $0.00 |